^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

AR-V7 negative

Phase 2
Sidney Kimmel Comprehensive Cancer Center at Jo...
Completed
Last update posted :
02/03/2022
Initiation :
03/15/2016
Primary completion :
12/03/2020
Completion :
10/06/2021
AR
|
AR expression • AR splice variant 7 • AR-V7 expression • AR-V7 positive • AR-V7 negative • AR splice variant 7 expression • AR splice variant 7 negative
|
Opdivo (nivolumab) • Yervoy (ipilimumab) • Xtandi (enzalutamide capsule)